Abirami Veluchamy

2.1k total citations
16 papers, 453 citations indexed

About

Abirami Veluchamy is a scholar working on Physiology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Abirami Veluchamy has authored 16 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Abirami Veluchamy's work include Pain Mechanisms and Treatments (6 papers), Pain Management and Opioid Use (3 papers) and Genetic Associations and Epidemiology (3 papers). Abirami Veluchamy is often cited by papers focused on Pain Mechanisms and Treatments (6 papers), Pain Management and Opioid Use (3 papers) and Genetic Associations and Epidemiology (3 papers). Abirami Veluchamy collaborates with scholars based in United Kingdom, Netherlands and Canada. Abirami Veluchamy's co-authors include Harry L. Hébert, Blair H. Smith, Nicola Torrance, Weihua Meng, Sundararajan Srinivasan, Ewan R. Pearson, Lesley Colvin, Yiling Zhou, Jennifer M. Watson and K. Anand Solomon and has published in prestigious journals such as Pain, Diabetologia and European Respiratory Journal.

In The Last Decade

Abirami Veluchamy

15 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abirami Veluchamy United Kingdom 10 216 84 83 82 65 16 453
Candace Bramson United States 15 329 1.5× 46 0.5× 317 3.8× 38 0.5× 81 1.2× 36 823
Jan B. Groener Germany 19 345 1.6× 214 2.5× 42 0.5× 180 2.2× 56 0.9× 37 802
Cira Antonietta Forte Italy 12 51 0.2× 52 0.6× 31 0.4× 20 0.2× 39 0.6× 20 355
Kara Mizokami‐Stout United States 14 162 0.8× 130 1.5× 30 0.4× 259 3.2× 23 0.4× 32 631
Paula Burger United States 6 171 0.8× 78 0.9× 93 1.1× 17 0.2× 92 1.4× 9 564
Lael Reinstatler United States 13 172 0.8× 22 0.3× 105 1.3× 115 1.4× 51 0.8× 35 739
Yan Xiong China 9 151 0.7× 26 0.3× 42 0.5× 71 0.9× 21 0.3× 19 477
Nancy Janiczek United States 4 142 0.7× 69 0.8× 74 0.9× 14 0.2× 86 1.3× 7 493
Mary B. Wilwerding United States 6 163 0.8× 8 0.1× 26 0.3× 99 1.2× 65 1.0× 7 508

Countries citing papers authored by Abirami Veluchamy

Since Specialization
Citations

This map shows the geographic impact of Abirami Veluchamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abirami Veluchamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abirami Veluchamy more than expected).

Fields of papers citing papers by Abirami Veluchamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abirami Veluchamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abirami Veluchamy. The network helps show where Abirami Veluchamy may publish in the future.

Co-authorship network of co-authors of Abirami Veluchamy

This figure shows the co-authorship network connecting the top 25 collaborators of Abirami Veluchamy. A scholar is included among the top collaborators of Abirami Veluchamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abirami Veluchamy. Abirami Veluchamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Richardson, Hollian, Clare Clarke, Abirami Veluchamy, et al.. (2025). The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC). European Respiratory Journal. 66(4). 2500287–2500287.
2.
Hébert, Harry L., Abirami Veluchamy, Georgios Baskozos, et al.. (2022). Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study. Journal of Neurology. 270(2). 1076–1094. 2 indexed citations
3.
Siddiqui, Moneeza K., Ranjit Mohan Anjana, Adem Y. Dawed, et al.. (2022). Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function. Diabetologia. 65(6). 973–983. 53 indexed citations
4.
Veluchamy, Abirami, et al.. (2022). Characteristics of non-fatal overdoses and associated risk factors in patients attending a specialist community-based substance misuse service. British Journal of Pain. 16(4). 458–466. 5 indexed citations
5.
Keir, Holly R., Hollian Richardson, Abirami Veluchamy, et al.. (2022). The Cathelicidin LL-37 and microbial dysbiosis in COPD patients receiving inhaled corticosteroids. 185–185. 1 indexed citations
6.
Hébert, Harry L., Abirami Veluchamy, Georgios Baskozos, et al.. (2021). Cohort profile: DOLORisk Dundee: a longitudinal study of chronic neuropathic pain. BMJ Open. 11(5). e042887–e042887. 8 indexed citations
7.
Veluchamy, Abirami, Harry L. Hébert, Natalie R. van Zuydam, et al.. (2021). Association of Genetic Variant at Chromosome 12q23.1 With Neuropathic Pain Susceptibility. JAMA Network Open. 4(12). e2136560–e2136560. 19 indexed citations
8.
Torrance, Nicola, Abirami Veluchamy, Yiling Zhou, et al.. (2020). Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. British Journal of Anaesthesia. 125(2). 159–167. 67 indexed citations
9.
Smith, Blair H., Harry L. Hébert, & Abirami Veluchamy. (2020). Neuropathic pain in the community: prevalence, impact, and risk factors. Pain. 161(Supplement 1). S127–S137. 59 indexed citations
10.
Veluchamy, Abirami, et al.. (2018). Systematic review and meta-analysis of genetic risk factors for neuropathic pain. Pain. 159(5). 825–848. 54 indexed citations
11.
Hébert, Harry L., Keith Milburn, Abirami Veluchamy, et al.. (2017). Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS). International Journal of Epidemiology. 47(2). 380–381j. 56 indexed citations
12.
Siddiqui, Moneeza K., Abirami Veluchamy, Cyrielle Maroteau, et al.. (2017). CKM Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia. Circulation Cardiovascular Genetics. 10(4). 3 indexed citations
13.
Mahmoudpour, Seyed Hamidreza, Abirami Veluchamy, Moneeza K. Siddiqui, et al.. (2016). Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenetics and Genomics. 27(3). 112–119. 13 indexed citations
14.
Hébert, Harry L., Abirami Veluchamy, Nicola Torrance, & Blair H. Smith. (2016). Risk factors for neuropathic pain in diabetes mellitus. Pain. 158(4). 560–568. 80 indexed citations
15.
Chang, Cheng, Abirami Veluchamy, Harry L. Hébert, et al.. (2016). A Genome-Wide Association Study Provides New Evidence That CACNA1C Gene is Associated With Diabetic Cataract. Investigative Ophthalmology & Visual Science. 57(4). 2246–2246. 13 indexed citations
16.
Solomon, K. Anand, Sundararajan Srinivasan, & Abirami Veluchamy. (2009). QSAR Studies on N-aryl Derivative Activity Towards Alzheimer’s Disease. Molecules. 14(4). 1448–1455. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026